Stryker Corporation (LON:0R2S)
London
· Delayed Price · Currency is GBP · Price in USD 364.67
-0.02 (0.00%)
Dec 5, 2025, 4:55 PM BST
Revenue Breakdown
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Instruments Revenue | 3.05B | 2.83B |
Log In |
Log In |
Log In | Upgrade
|
| Endoscopy Revenue | 3.67B | 3.39B |
Log In |
Log In |
Log In | Upgrade
|
| Medical Revenue | 4.06B | 3.85B |
Log In |
Log In |
Log In | Upgrade
|
| Neurovascular Revenue | 1.77B | 1.31B |
Log In |
Log In |
Log In | Upgrade
|
| Neuro Cranial Revenue | 2.42B | 2.14B |
Log In |
Log In |
Log In | Upgrade
|
| MedSurg & Neurotechnology Revenue | 14.97B | 13.52B |
Log In |
Log In |
Log In | Upgrade
|
| Knees Revenue | 2.59B | 2.45B |
Log In |
Log In |
Log In | Upgrade
|
| Hips Revenue | 1.83B | 1.70B |
Log In |
Log In |
Log In | Upgrade
|
| Trauma and Extremities Revenue | 3.86B | 3.51B |
Log In |
Log In |
Log In | Upgrade
|
| Spinal Implants Revenue | 363.00M | 707.00M |
Log In |
Log In |
Log In | Upgrade
|
| Other Orthopaedics Revenue | 770.00M | 712.00M |
Log In |
Log In |
Log In | Upgrade
|
| Orthopaedics Revenue | 9.41B | 9.08B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | -24.38B | -22.60B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 24.38B | 22.60B |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 2
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Revenue (Total) | 24.38B | 22.60B |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| United States Revenue | 18.44B | 16.94B |
Log In |
Log In |
Log In | Upgrade
|
| International Revenue | 5.94B | 5.65B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 24.38B | 22.60B |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| MedSurg & Neurotechnology Operating Income | 4.56B | 4.00B |
Log In |
Log In |
Log In | Upgrade
|
| Orthopaedics Operating Income | 2.64B | 2.59B |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | -3.53B | -2.91B |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 3.67B | 3.69B |
Log In |
Log In |
Log In | Upgrade
|
EBIT 2
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Operating Income (Total) | 3.67B | 3.69B |
Log In |
Log In |
Log In | Upgrade
|
Key Performance Indicators
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2019 |
| Organic Net Sales Growth | 10.20% |
Log In |
Log In |
Log In | Upgrade
|